Leading companies like COTY, ULTA and SBH are tapping tech, innovation and shifting trends to stay ahead in the fast-evolving beauty market.

OLLI's Q1 results may show solid sales gains, but rising costs and a soft start could pressure margins and earnings.

CHPT Q1 gross margin is likely to remain stable despite an anticipated drop in revenues.

Paul Sankey, Sankey Research president, joins 'Squawk on the Street' to discuss what's driving prices in the global oil market.

The Campbell's Company's Q3 earnings beat estimates, but weak guidance and ongoing debt concerns keep me cautious despite shares trading below my prior target. The Rao's acquisition adds growth potential, yet high leverage and slow EBITDA growth mean capital returns beyond dividends are years away. Snacking division underperforms with market share losses and margin pressure, offsetting relative strength in meals, beverages, and soup segments.

What if we told you that Adobe (NASDAQ: ADBE) stock is setting itself up for a huge gain opportunity? Adobe is set to report earnings on June 12, and if you're the kind of investor who likes to play short-term volatility with defined risk, there's an intriguing opportunity brewing.

A few months ago, I asked, "Is GPIQ better than JEPQ?" These are both prolific Nasdaq 100 covered call funds. At the time, I concluded that they were too similar for the differences to matter, but I was wrong about that. April's crash and recovery saw a massive gap form. This was largely caused by the differences in the two funds, which hadn't manifested so prominently in my last article.

Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.

ARLINGTON, Va.--(BUSINESS WIRE)--NEST, an initiative of MDIC, is pleased to welcome Hologic, a leading global medical device company, to its Governance Committee.

Transaction increases shareholder equity by approximately $3.5M As part of agreement, Mullen extinguishes significant debt, gains additional 21% ownership and regains full control of Bollinger Motors Bollinger to continue operating as a majority owned Mullen subsidiary; Mullen will continue to provide full financial backing on sales, service, and warranty of vehicles Bollinger to ramp up sales activity immediately while consolidating and streamlining operations BREA, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- via IBN -- Mullen Automotive Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an electric vehicle (“EV”) manufacturer, announces today that the Company has successfully acquired an additional 21% of …

The consensus price target hints at a 50.9% upside potential for Semtech (SMTC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The average of price targets set by Wall Street analysts indicates a potential upside of 59.9% in Spire (SPIR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 65.2% in Immunocore (IMCR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 93.6% in Vertical Aerospace (EVTL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 27.7% in European Wax Center (EWCZ). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 36.2% in Catalyst (CPRX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 90% in Backblaze (BLZE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The consensus price target hints at a 106.9% upside potential for Kamada (KMDA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The average of price targets set by Wall Street analysts indicates a potential upside of 285.3% in Candel Therapeutics (CADL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The consensus price target hints at a 131.3% upside potential for Oric Pharmaceuticals (ORIC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.